TSX/BHC (TSX/BHC)

Toronto Stock Exchange: TSX/BHC · CAD

CA$9.45

+0.58 (+6.5%)· Recorded snapshot

Market cap	3.5B
Revenue (ttm)	15.4B
Net income (ttm)	-1.6B
EPS (ttm)	-CA$4.14
P/E (forward)	1.4x
Volume	831,001
Beta	0.37

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15.4B
Net income (ttm): -1.6B
EPS (ttm): -CA$4.14
P/E (forward): 1.4x
Market cap: 3.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E1.4

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC13.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/BHC indicators

Market & fundamental data

Available fields

227

Groups with data

Currency

USD

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-10-28
Employees	20,300
Employees change	-400
Employees growth	-1.93%
Enterprise value	CAD 31.5B
Exchange	Toronto Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	CA0717341071
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split date	2000-10-05
Last stock split type	Forward
Market cap	CAD 3.5B
Next earnings date	2026-10-28
Price	CAD 9.45
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	tsx/BHC
Website	https://www.bauschhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-43.78%
EV/EBIT	8.14x
EV/EBITDA	5.55x
EV/FCF	15.4x
EV/Sales	2.05x
FCF / EV yield	6.49%
FCF yield	61.31%
Forward P/E	1.4x
Industry forward P/E	34.37x
P/(FCF - SBC) ratio	1.95x
P/(OCF - SBC) ratio	1.49x
P/FCF ratio	1.63x
P/OCF ratio	1.3x
P/S ratio	0.22x
Price/EBITDA ratio	0.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	25.21%
EBITDA margin	36.01%
FCF margin	13.34%
Gross margin	71.82%
Operating margin	25.21%
Pretax margin	-6.74%
Profit margin	-10.12%
Profit per employee	CAD -76,811
Profitable quarters	1
Profitable years	1
Revenue per employee	CAD 759,229
ROA	6.57%
ROA (5Y)	4.05%
ROCE	13.51%
ROIC	13.61%
ROIC (5Y)	4.19%
SBC / revenue	2.15%
Tax / revenue	3.33%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	70.41%
EPS growth quarters	1
EPS growth years	2
FCF growth	28.34%
FCF growth (Q)	212.11%
FCF growth (QoQ)	390.08%
FCF growth 5Y	3.6%
Gross profit growth	11.84%
Gross profit growth (Q)	17.78%
Gross profit growth 3Y	9.83%
Gross profit growth 5Y	5.17%
Net income growth (Q)	74.32%
Net income growth quarters	1
Net income growth years	2
OCF growth	19.52%
OCF growth (Q)	131.83%
OCF growth (QoQ)	191.3%
OCF growth 10Y	-2.67%
OCF growth 5Y	3.88%
Operating income growth	43.85%
Operating income growth (Q)	69.58%
Operating income growth 3Y	23.83%
Operating income growth 5Y	10.06%
Revenue growth	10.09%
Revenue growth (Q)	12.73%
Revenue growth (QoQ)	13%
Revenue growth 10Y	0.49%
Revenue growth 3Y	9.13%
Revenue growth 5Y	5.06%
Revenue growth quarters	3
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -524M
Depreciation and amortization	CAD 1.6B
EBIT	CAD 3.9B
EBITDA	CAD 5.5B
EPS	CAD -4.14
Financing cash flow	CAD -1.6B
Free cash flow	CAD 2B
Free cash flow minus SBC	CAD 1.7B
Gross profit	CAD 11.1B
Income taxes	CAD 512.7M
Investing cash flow	CAD -847.8M
Net borrowing	CAD -1.4B
Net cash flow	CAD 134.9M
Net income	CAD -1.6B
Operating cash flow minus SBC	CAD 2.2B
Operating income	CAD 3.9B
Revenue	CAD 15.4B
Stock-based compensation	CAD 330.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.34
Book value per share	CAD -6.73
Debt / EBITDA	5.18
Debt / FCF	14.52
Goodwill	CAD 13.7B
Interest coverage	1.7
Long-term assets	CAD 26.1B
Long-term liabilities	CAD 30B
Net cash (debt)	CAD -26.9B
Net cash / market cap	-812.07%
Net debt / EBITDA	4.85
Net debt / FCF	13.25
Piotroski F-Score	7
Property, plant and equipment	CAD 2.9B
Shareholders' equity	CAD -1.1B
Tangible book value	CAD -22.4B
Tangible book value per share	CAD -59.79
Total assets	CAD 35.2B
Total cash	CAD 2.6B
Total debt	CAD 29.5B
Total liabilities	CAD 36.3B
WACC	6.13%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.42
Current assets	CAD 9.2B
Current liabilities	CAD 6.4B
Current ratio	1.44
Inventory turnover	1.88
Net working capital	CAD 1.5B
Quick ratio	0.9
Working capital	CAD 2.8B
Working capital turnover	8.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.45%
Dividend growth (3Y)	-13.82%
Dividend per share	CAD 0.00
Last dividend	CAD 1.00
Shareholder yield	-0.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-68.01%
10Y return CAGR	-10.77%
10Y total return	-68.01%
150-day SMA	CAD 7.84
15Y price change	-76.67%
15Y return CAGR	-9.25%
15Y total return	-76.67%
1D price change	6.54%
1M price change	17.25%
1M total return	17.25%
1W price change	4.88%
1W total return	4.88%
1Y price change	8.5%
1Y return CAGR	8.5%
1Y total return	8.5%
20-day SMA	CAD 8.74
200-day SMA	CAD 7.89
20Y price change	-46.61%
20Y return CAGR	-1.48%
20Y total return	-25.76%
3M price change	49.05%
3M total return	49.05%
3Y price change	3.73%
3Y return CAGR	1.23%
3Y total return	3.73%
50-day SMA	CAD 8.66
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 11.08
52-week high date	2026-01-07
52-week low	CAD 6.10
52-week low date	2026-07-21
5Y price change	-72.44%
5Y return CAGR	-22.73%
5Y total return	-72.44%
6M price change	24.02%
6M total return	24.02%
All-time high	CAD 347.84
All-time high date	2015-08-06
All-time low	CAD 0.46
All-time low date	1994-04-19
Average true range (ATR)	CAD 0.34
Average volume	459.6K
Beta (5Y)	0.37
Change from 52-week high	-14.71%
Change from 52-week low	54.92%
Change from all-time high	-97.28%
Change from all-time low	1,961.97%
Change from open	6.54%
Day's gap	0%
Dollar volume	CAD 7.9M
High price	CAD 9.58
Low price	CAD 8.80
Monthly RSI	50.24
Open price	CAD 8.87
Position in 52-week range	83.33%
Previous close	CAD 8.87
Price vs 150-day SMA	20.54%
Price vs 20-day SMA	8.17%
Price vs 200-day SMA	19.76%
Price vs 50-day SMA	9.07%
Relative volume	1.84
RSI	67.32
Sharpe ratio	0.34
Sharpe ratio (3Y)	0.17
Sharpe ratio (5Y)	-0.14
Sortino ratio	0.72
Sortino ratio (3Y)	0.36
Sortino ratio (5Y)	-0.11
Volume	831K
Weekly RSI	60.87
YTD price change	-0.84%
YTD total return	-0.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	260.6M
Shares change (QoQ)	1.42%
Shares change (YoY)	0.45%
Shares held by insiders	10.73%
Shares held by institutions	36.59%
Short % of float	0.92%
Short % of shares	0.78%
Short ratio	2.5 days

Deeper analysis on TSX/BHC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/BHC report

Is a complete TSX/BHC research report available?

No complete published report is available for tsx/BHC (TSX/BHC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/BHC (TSX/BHC)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/BHC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/BHC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/BHC

Frequently asked questions